Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 15 November 2021 224 - Subject
- Language
- ISSN
- 0223-5234